Live from the NIH registry
Studies recruiting near Springfield right now
Top 25 of 154 recruiting studies, sorted by proximity — each links to its official registry page
Real-world Experience of Catheter Ablation for the Treatment of Arrhythmias
Paroxysmal Atrial Fibrillation, Persistent Atrial Fibrillation
N/A
Observational 20,000 participants sought
CoxHealth — Springfield, Missouri (1.5 mi)
· Sponsor: Heart Rhythm Clinical and Research Solutions, LLC
Reaching Rural Cancer Survivors Who Smoke Using Text-Based Program
Cigarette Smoking-Related Carcinoma
Phase 3
Interventional 600 participants sought
Mercy Hospital Springfield — Springfield, Missouri (1.5 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
Breast Neoplasms, Neoplasm Metastasis
Phase 3
Interventional 800 participants sought
Oncology Hematology Associates — Springfield, Missouri (1.5 mi)
· Sponsor: Eli Lilly and Company
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
Castration Levels of Testosterone, Metastatic Prostatic Adenocarcinoma
Phase 3
Interventional 1,273 participants sought
Mercy Hospital Springfield — Springfield, Missouri (1.5 mi)
· Sponsor: SWOG Cancer Research Network
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
Fallopian Tube Endometrioid Adenocarcinoma, Fallopian Tube High Grade Serous Adenocarcinoma
Phase 3
Interventional 880 participants sought
Mercy Hospital Springfield — Springfield, Missouri (1.5 mi)
· Sponsor: NRG Oncology
A Research Study Comparing How Well Different Doses of the Medicine NNC0662-0419 Lower Blood Sugar in People With Type 2 Diabetes
Diabetes Mellitus, Type 2
Phase 2
Interventional 270 participants sought
Headlands Research — Springfield, Missouri (1.5 mi)
· Sponsor: Novo Nordisk A/S
Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps
Adenocarcinoma of the Colon, Adenocarcinoma of the Rectum
N/A
Interventional 9,500 participants sought
Mercy Hospital Springfield — Springfield, Missouri (1.5 mi)
· Sponsor: NRG Oncology
Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab
Anatomic Stage II Breast Cancer AJCC v8, Early Stage Triple-Negative Breast Carcinoma
Phase 3
Interventional 1,295 participants sought
Mercy Hospital Springfield — Springfield, Missouri (1.5 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight
Overweight, Obesity
Phase 2
Interventional 400 participants sought
Clinvest Headlands Llc — Springfield, Missouri (1.5 mi)
· Sponsor: Eli Lilly and Company
A Long-Term Safety Study of Elismetrep (K-304) in the Acute Treatment of Migraine
Acute Migraine
Phase 3
Interventional 1,000 participants sought
Clinvest Headlands LLC — Springfield, Missouri (1.5 mi)
· Sponsor: TriGemX Bio, Inc.
ARTEMIS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With a Heart Attack
Cardiovascular Risk, Acute Myocardial Infarction (AMI)
Phase 3
Interventional 10,000 participants sought
Mercy Research — Springfield, Missouri (1.5 mi)
· Sponsor: Novo Nordisk A/S
Pan-tumor MRD Study
Muscle Invasive Bladder Urothelial Carcinoma, Esophageal Cancer
N/A
Observational 1,350 participants sought
Cox Health — Springfield, Missouri (1.5 mi)
· Sponsor: Paradigm Health
A Clinical Study to Investigate the Safety and Tolerability of Efimosfermin Alfa Injection in Participants With Known or Suspected F2- or F3-stage MASH
Non-alcoholic Fatty Liver Disease
Phase 3
Interventional 1,250 participants sought
GSK Investigational Site — Springfield, Missouri (1.5 mi)
· Sponsor: GlaxoSmithKline
Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma
Cutaneous Melanoma, Stage II
N/A
Interventional 2,998 participants sought
Cox South Hospital — Springfield, Missouri (1.5 mi)
· Sponsor: Melanoma and Skin Cancer Trials Limited
A Study of Azenosertib (ZN-c3) in Subjects With Platinum-Resistant High-Grade Serous Ovarian, Fallopian Tube or Primary Peritoneal Cancer
High-Grade Serous Ovarian, Fallopian Tube or Primary Peritoneal Cancer
Phase 2
Interventional 310 participants sought
Site 0226 - CoxHealth — Springfield, Missouri (1.5 mi)
· Sponsor: K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc
This Study is a Non-interventional Disease Registry of Adolescent and Adult Patients With Atopic Dermatitis Who Initiate or Switch Any Systemic Treatment
Atopic Dermatitis
N/A
Observational 1,000 participants sought
Red River Research Partners, Llc- Site Number : 8400054 — Bolivar, Missouri (29.8 mi)
· Sponsor: Sanofi
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes
Obesity or Overweight
Phase 3
Interventional 2,000 participants sought
Clinvest Research LLC — Springfield, Missouri (1.5 mi)
· Sponsor: Hoffmann-La Roche
Testing the Addition of MEDI4736 (Durvalumab) to Chemotherapy Before Surgery for Patients With High-Grade Upper Urinary Tract Cancer
Renal Pelvis and Ureter Urothelial Carcinoma
Phase 2, Phase 3
Interventional 131 participants sought
Mercy Hospital Springfield — Springfield, Missouri (1.5 mi)
· Sponsor: National Cancer Institute (NCI)
A Master Protocol Study (LY900028) of Multiple Intervention-Specific-Appendices (ISAs) in Participants With Chronic Pain
Osteoarthritis, Knee, Diabetic Neuropathic Pain
Phase 2
Interventional 10,000 participants sought
Clinvest Research LLC — Springfield, Missouri (1.5 mi)
· Sponsor: Eli Lilly and Company
DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer
Endometrial Cancer
Phase 3
Interventional 600 participants sought
Research Site — Springfield, Missouri (1.5 mi)
· Sponsor: AstraZeneca
A Clinical Trial to Learn About the Effects of VHB937 in People With Early Alzheimer's Disease
Alzheimer's Disease
Phase 2
Interventional 407 participants sought
Citizens Memorial Hospital Neurology CLinic — Bolivar, Missouri (29.8 mi)
· Sponsor: Novartis Pharmaceuticals
Testing Docetaxel-Cetuximab or the Addition of an Immunotherapy Drug, Atezolizumab, to the Usual Chemotherapy and Radiation Therapy in High-Risk Head and Neck Cancer
Oropharyngeal p16INK4a-Negative Squamous Cell Carcinoma, Stage III Hypopharyngeal Squamous Cell Carcinoma AJCC v7
Phase 2, Phase 3
Interventional 613 participants sought
Mercy Hospital Springfield — Springfield, Missouri (1.5 mi)
· Sponsor: National Cancer Institute (NCI)
Tempus CRC Surveillance Study: A ctDNA Biomarker Profiling Study of Patients With CRC Using NGS Assays
Colorectal Cancer
N/A
Observational 300 participants sought
Mercy Clinic Cancer and Hematology - Chub O'Reilly Cancer Center — Springfield, Missouri (1.5 mi)
· Sponsor: Tempus AI
Shorter Chemo-Immunotherapy Without Anthracycline Drugs for Early-Stage Triple Negative Breast Cancer
Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8
Phase 3
Interventional 2,400 participants sought
Mercy Hospital Springfield — Springfield, Missouri (1.5 mi)
· Sponsor: SWOG Cancer Research Network
Patient Retrospective Outcomes (PRO)
Chronic Pain
N/A
Observational 15,000 participants sought
Mercy Medical Research Institute — Springfield, Missouri (1.5 mi)
· Sponsor: Boston Scientific Corporation